Bi-allelic UQCC1 variants impair mitochondrial complex III assembly causing early-onset mitochondrial disease

Inside every cell of the human body, tiny power plants called mitochondria work tirelessly to generate the energy required for life. These organelles rely on a sophisticated assembly line of molecular machines to convert food into fuel. One of the most critical machines in this line is a structure known as complex III. It acts as a central hub, passing electrons along a chain to help produce the energy currency that powers our muscles, brain, and heart. For this machine to function, it must be built with extreme precision. While some of its parts are made inside the mitochondria themselves, the majority are constructed in the cell's main nucleus and then shipped over. If the instructions for building or assembling these parts are flawed, the entire machine can fail, leading to severe illness, often appearing in early childhood.

Scientists have long known that errors in the genes coding for the structural parts of complex III can cause disease. However, the process of assembling these parts also requires a set of helper proteins, known as assembly factors, which act like specialized foremen to guide the construction. Until now, one specific helper protein, called UQCC1, had not been linked to human illness, even though it was known to interact with other essential components of the assembly line. A team of researchers from around the world has now identified a new cause of mitochondrial disease by finding that errors in the gene for UQCC1 prevent complex III from being built correctly. By studying nine children from eight different families, the team demonstrated that without a working UQCC1, the power plant's central machine cannot form, leading to a dangerous buildup of acid in the blood and a failure of the body's energy systems.

The researchers began by gathering clinical data on nine affected children who shared a pattern of severe symptoms, including low muscle tone, seizures, and dangerously high levels of lactic acid in their blood. Using advanced genetic sequencing, they examined the DNA of these children and their parents. In every case, they found that the children had inherited two broken copies of the UQCC1 gene, one from each parent. These errors ranged from small typos in the genetic code to larger deletions that removed significant sections of the gene. In some families, the parents were related, which increased the chance of both carrying the same rare genetic flaw, but the condition appeared in unrelated families as well, confirming that the gene itself was the culprit.

To understand how these genetic errors caused disease, the scientists turned to the children's own cells. They grew skin cells from the patients in the laboratory and compared them to cells from healthy people. They found that in the patient cells, the UQCC1 protein was either missing entirely or present in very low amounts. Because UQCC1 works closely with a partner protein called UQCC2 to stabilize the assembly process, the lack of UQCC1 also caused the levels of UQCC2 to drop. This double loss meant that the early stages of building complex III were disrupted. When the researchers looked at the mitochondria in these cells, they saw that the complex III machine was not forming properly. Instead of a complete, functional machine, the cells had very few of the finished structures, and the ones that did exist were unstable.

The team used a technique called mass spectrometry to watch the assembly process in real time. They labeled newly made proteins with a heavy marker so they could distinguish them from older proteins. In healthy cells, these new parts were quickly incorporated into the complex III machine and then into larger super-structures that help the respiratory chain work efficiently. In the patient cells, however, the new parts failed to join the machine correctly. They accumulated in strange, incomplete clusters or failed to reach the final assembly stage. This confirmed that the problem was not just a lack of parts, but a fundamental breakdown in the construction process itself. The researchers also observed that the failure of complex III had a ripple effect, causing secondary issues with other energy-producing complexes, which explained the severity of the symptoms in the children.

To prove that the UQCC1 gene was indeed the cause of the problem, the researchers performed a rescue experiment. They took the patient cells and introduced a healthy, working copy of the UQCC1 gene using a harmless virus as a delivery vehicle. Once the cells began producing the normal UQCC1 protein again, the levels of the partner protein UQCC2 recovered, and the assembly of complex III was restored. The cells regained the ability to build the complex III machine, and the activity of the machine increased significantly. This direct reversal of the defect provided the final, definitive proof that the genetic errors in UQCC1 were responsible for the disease.

The study also used computer modeling to visualize how the specific genetic errors damaged the protein. The researchers found that the mutations caused the protein to fold into the wrong shape or prevented it from binding to its partner protein. In some cases, the errors were so severe that the protein was destroyed before it could do any work. In others, the protein was unstable and fell apart quickly. These structural insights helped explain why different mutations led to varying degrees of severity in the patients. For instance, one child had a mutation that left a small amount of functional protein, and this child showed a milder reduction in the complex III machine compared to others who had almost no protein at all.

This discovery fills a significant gap in our understanding of mitochondrial disease. It establishes UQCC1 as a critical gene for human health and provides a clear explanation for a group of patients who previously had no diagnosis. By identifying the specific genetic cause, doctors can now offer families a definitive answer and potentially screen for the condition in future pregnancies. The findings also highlight the importance of assembly factors in human biology, showing that even if the main parts of a machine are perfect, the process of putting them together is just as vital. For the families involved, this research transforms a mystery into a known condition, opening the door for better management and future therapeutic strategies.